In a major step toward digital asset integration, Wellgistics Health (NASDAQ: WGRX) has filed an S-1 with the U.S. SEC detailing its strategy to employ XRP and the XRP Ledger (XRPL) for instant, cost-efficient payment solutions. The move has caught the attention of Ripple-affiliated lawyer Bill Morgan, who noted its broader significance for accelerating institutional crypto adoption.
XRPL Enters the Healthcare Sphere
Based in Florida, Wellgistics Health operates a vast distribution network for independent pharmacies and manufacturers. The company has now begun utilizing the XRP Ledger to process real-time, low-fee transactions, signaling an active shift from simply holding XRP to deploying it for operational payments between internal divisions and external partners.
According to its SEC filing, Wellgistics also plans to use its existing XRP as collateral for financing, raise additional capital for further token acquisition, and generate yield from its XRP holdings—what Bill Morgan described as “XRP working hard for WH.”
This approach exemplifies an evolving view among publicly listed firms, especially those operating in highly regulated industries. Leveraging XRPL’s speed and affordability matches Wellgistics’ goals to streamline the healthcare supply chain.
“Tangible Utility” in Action
Bill Morgan, well known for his Ripple-related commentary, praised Wellgistics’ multi-use XRP strategy. He pointed out that the company’s framework—using XRP as a treasury asset, collateral, payment tool, and income generator—offers a comprehensive, real-world example of blockchain utility.
Morgan suggested this case directly rebuts critics who claim that XRP lacks genuine use beyond speculation, showing that the network is enabling practical, day-to-day efficiencies in a traditional sector.
Commitment Despite Regulatory Hurdles
In its SEC filing, Wellgistics recognized the risks posed by regulatory uncertainty around XRP, given the ongoing Ripple v. SEC litigation. However, the company is moving forward, investing heavily in XRPL infrastructure.
Backing up its commitment, Wellgistics secured a $50 million equity line from LDA Capital—enabling it to access capital by issuing shares as needed. This financial flexibility is expected to speed up XRPL adoption for its nationwide footprint of 6,000+ pharmacies and 150 manufacturers.
A Broader Institutional Trend
Wellgistics joins other public companies, like Nature’s Miracle and Mercado Bitcoin, in leveraging XRPL for asset tokenization and payment rails. Ripple’s partnership with Mercado Bitcoin, which seeks to tokenize $200 million in assets on XRPL, shows the network’s rising appeal for institutions seeking regulated, scalable solutions.
Leadership: “Our Bet Is on Infrastructure, Not Inertia”
Wellgistics CEO Brian Norton captured the vision in a recent statement:
“The future winners in healthcare won’t be those with the largest buildings—they’ll be those with the fastest rails, best data, and most efficient platforms. We are betting on infrastructure—not inertia.”
This outlook reflects Wellgistics’ conviction that blockchain, and XRPL in particular, can deliver a more dynamic, data-driven healthcare supply chain. Despite ongoing legal uncertainties, the firm is forging ahead, confident that XRPL’s efficiency and scale will generate real value throughout its healthcare operations.
